J.C. Thompson, R. Fan, T. Black, G.H. Yu, S.L. Savitch, A. Chien, S. Yee, M. Sen, W. Hwang, S.I. Katz, M. Feldman, A. Vachani, E.L. Carpenter.: Measurement and Immunophenotyping of pleural EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients. Lung Cancer 127 : 25-33,2019.
C. Aggarwal*, J.C Thompson*, T. Black, S. Katz, R. Fan, S.S Yee, A. Chien, T.L. Evans, J. Bauml, E. Alley, C. Ciunci, A. Berman, R. Cohen, D. Lieberman, K. Majmundar, S.L Savitch, J.D. Morrissette, W. Hwang, K. Elenitoba-Johnson, C.J. Langer, E.L. Carpenter.: Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non–small cell lung cancer. JAMA Oncology 5 (2): 173-180,2019.
C. Aggarwal, C. Davis, R. Mick, J.C. Thompson, S. Ahmed, S. Jeffries, S. Bagley, P. Gabriel, T.L. Evans, J. Bauml, C. Ciunci, E. Alley, J.D. Morrissette, R. Cohen, E.L. Carpenter, C. Langer: Influence of TP53 Mutation on Survival and Transformation to Small Cell Lung Cancer in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer JCO Precision Oncology published on line : 2018.
S. Katz, M. Hammer, S.J. Bagley, C. Aggarwal, J. Bauml, J.C. Thompson, A.C. Nachiappan, C.B. Simone, C. Langer.: Radiologic pseudoprogression during anti-PD1 therapy for advanced non-small lung cancer. J Thorac Oncol.
13 (7): 978-986,2018.
A. Klampatsa, S. O’Brien, E. Eruslanov, A. Rao, J.C. Thompson, S. Kim, K. Cengel, E. Moon, S. Singhal, S. Albelda: Phenotypic and Functional Analysis of Malignant Mesothelioma Tumor-Infiltrating Lymphocytes (TILs). Internal Conference of the International Mesothelioma Interest Group. Ottawa, Canada. : 2018.
E. Moon. S. O’brien, J.C. Thompson, S. Kim, K. Ma, D. Dibardino. A. Lanfranco, A. Vachani, A. Haas, S. Albelda.: A Pilot study of endobronchial guided transbronchial needle aspiration for immunophenotyping the lung cancer tumor microenvironment. American Thoracic Society Conference. San Diego, CA. : 2018.
J.C.Thompson, S.L. Savitch, R. Fan, S.S Yee, C.A. Powers, G. Yu, L. Gebrian, D. Smirnov, C. Rao, S. Gross, M. Feldman, A. Vachani, E.L. Carpenter: The use of circulating tumor cell technology for the characterization of tumor cells and assessment of PD-L1 expression in pleural effusions of metastatic non-small cell lung cancer patients. Association of Clinical and Translational Science. Washington, D.C. : 2018.
E. Bange*, M. Marmarelis*, W. Hwang, Y. Yang, J.C. Thompson, J. Bauml, C.Ciunci, E. Alley, T. Evans, J. Morrissette, R. Cohen, C. Langer, E. Carpenter, C. Aggarwal.: Impact of KRAS and TP53 co-mutations on outcomes following 1st-line therapy among patient with LKB1/STK11 mutated stage IV NSCLC. American Association for Cancer Research Annual Meeting, Chicago, IL.
M. Marmarelis, J.C. Thompson, C. Aggarwal, T.L. Evans, E. Carpenter. R.B. Cohen, C.J. Langer, J. Bauml.: Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer.
Ann Transl Med.
5 (18): 380,2017.
S.J. Bagley, S. Kothari, C. Aggarwal, J. Bauml, E. Alley, T.L Evans, J.A. Kosteva, C. Ciunci, J.C. Thompson, S. Stonehouse-Lee, V.E. Sherry, E. Gilbert, B. Sandy, F. Mutale, G. DiLullo, R.B. Cohen, A. Vachani, C. Langer.: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab treated patients with advanced non-small cell lung cancer. Lung Cancer 106 : 1-7,2017.
DE Schwed Lustgarten, J.C. Thompson, G Yu, A Vachani, B Vaidya, C Rao, M Connelly, M Udine, KS Tan, D. Heitjan, S Albelda: Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Annals of the American Thoracic Society 10 (6): 582-9,2013.
J. C. Thompson, S.S Yee, A.B. Troxel, S.L. Savitch, R. Fan, D. Balli, D.B. Lieberman, J.D Morrissette, T.L Evans, J. Bauml, C. Aggarwal, J.A Kosteva, E. Alley, C. Ciunci, R.B. Cohen, S. Bagley, S. Stonehouse-Lee, V.E. Sherry, E. Gilbert, C. Langer, A. Vachani, E. Carpenter: Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA. Clinical Cancer Research 22 (23): 5772-5782,2016.